Cuprior - European Medicines Agency (EMA)
Cuprior is a medicine used to treat patients aged 5 years and older with Wilson's disease, a genetic condition in which copper absorbed from food builds up in the body, particularly in the …
Home - Cuprior
2023年2月2日 · Select your location below to view the Cuprior ® Patient Information Leaflet (PIL) in your language.
Cuvrior(四盐酸盐曲恩汀)用于肝豆状核变性中文说明书|香港济民药 …
CUVRIOR是一种铜螯合剂，适用于治疗脱铜且对青霉胺耐受的稳定型威尔逊病成年患者。 • CUVRIOR在成人中的起始日总剂量为300毫克至3,000毫克，分次口服（每天2次）。 从青霉 …
Cuprior is a medicine used to treat Wilson’s disease that contains the active substance trientine. Wilson’s disease is an inherited condition in which the body cannot transport copper around …
Cuprior 150 mg film-coated tablets - Summary of Product
2024年4月30日 · Cuprior is for oral use. The film-coated tablets should be swallowed with water. The scored film-coated tablet can be divided in two equal halves, if required, to provide a more …
What is Cuprior and what is it used for? Cuprior is a medicine used to treat patients aged 5 years and older with Wilson’s disease, a genetic condition in which copper absorbed from food …
威尔逊病青霉胺替代药！FDA批准Cuvrior(四盐酸盐曲恩汀) - 知乎
据Orphalan SA 公司于5月2日宣布， 美国食品药品监督管理局 (FDA)已批准Cuvrior (trientine tetrahydrochloride，四盐酸盐曲恩汀)，用于治疗患有脱铜且对青霉胺耐受的成人稳定型威尔 …
Cuprior is indicated for the treatment of Wilson’s disease in adults, adolescents and children ≥ 5 years intolerant to D-penicillamine therapy. Treatment should only be initiated by specialist …
威尔逊病新药！FDA批准Cuvrior(四盐酸盐曲恩汀) - 健康界
2022年5月12日 · 据Orphalan SA公司于5月2日宣布，美国食品药品监督管理局 (FDA)已批准Cuvrior (trientine tetrahydrochloride，四盐酸盐曲恩汀)，用于治疗患有脱铜且对青霉胺耐受的 …
Cuprior 治疗威尔逊病 - 知乎 - 知乎专栏
Cuprior 用于治疗5岁及以上的成人、青少年和儿童的威尔逊病，适用于对D-青霉胺疗法不耐受的患者。 每片 Cuprior 含有299.61毫克的…